GL1X · GenesisL1 explorer

MolNFT v1 · #133117 · protein

Pandda analysis group deposition -- crystal structure of SARS-cov-2 helicase in complex with Z2027049478

5RLY: “Pandda analysis group deposition -- crystal structure of SARS-cov-2 helicase in complex with Z2027049478”. X-ray diffraction, 3 ligands (K34, ZN, PO4), 10 pockets (best druggability 0.74). MolNFT v1 #133117 on GenesisL1: 3D…

PDB
5RLY
Type
protein
Length
1,157 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Helicase
EC
3.6.4.12, 3.6.4.13
UniProt
P0DTD1
Ligands
K34, ZN, PO4
Pockets
10 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 29% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHelicase (EC 3.6.4.12, 3.6.4.13)protein57229% helix, 24% strandP0DTD1
BHelicase (EC 3.6.4.12, 3.6.4.13)protein58529% helix, 24% strandP0DTD1

Ligands and binding sites

  • K34 · 5-(1,3-thiazol-2-yl)-1H-1,2,4-triazole · ligand · 3 copies · chains A, B
  • ZN · Zinc ion · metal · 6 copies · chains A, B
  • PO4 · Phosphate ion · ion · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 7 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13860.740.8446empty
23200.720.8447empty
35910.710.8068PO4
43200.650.8044empty
53040.640.8141empty

Interfaces

1 interface between chains.

  • A–B · 758 Ų buried · 7 hydrogen bonds · protein-protein

Compared structures

  • 5RLY · PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.